Omicron Update

As we head into a second holiday season with Covid still a concern, I want to share an update on the Omicron variant, boosters, and new vaccines and treatments in the pipeline. Please keep in mind that our knowledge of Omicron is preliminary at this point and much more will be learned in the next few weeks. I will continue … Read More

Successful Phase 1 FDA Trial Evaluating Poly-Zinc-Liothyronine (PZL)

Publication of the successful Phase 1 FDA trial evaluating Poly-Zinc-Liothyronine (PZL), a novel extended release T3 product discovered and developed by Synthonics to help manage difficult to treat hypothyroidism and other medical disorders, in Thyroid. If eventually approved by the FDA, PZL would significantly improve the quality of life of millions of individuals that suffer from hypothyroidism, potentially help patients … Read More